Torrent Pharmaceuticals has received a demand notice from the National Pharmaceutical Pricing Authority (NPPA) regarding alleged overcharging on five drugs. The notice, dated September 24, 2025, pertains to the period between January 2016 and November 2018. The penalty proposed by the NPPA amounts to ₹6,63,07,606. The company is currently assessing the matter, but anticipates no material impact on its financials or operations.
Demand Notice Details
Torrent Pharmaceuticals has been notified of a demand notice issued by the National Pharmaceutical Pricing Authority (NPPA). The notice alleges overcharging on certain drugs and proposes a penalty.
Key Details of the Notice
The demand notice, dated September 24, 2025, was issued by the NPPA. It concerns alleged overcharging related to five drugs during the period from January 2016 to November 2018. The potential penalty associated with this notice is ₹6,63,07,606.
Company Assessment
Torrent Pharmaceuticals is currently evaluating the demand notice. Based on its initial assessment, the company believes that the notice will not have a material impact on its financial performance, operations, or other activities.
Source: BSE
